METHODS AND COMPOSITIONS FOR CONTINUOUS SINGLE-MOLECULE NUCLEIC ACID SEQUENCING BY SYNTHESIS WITH FLUOROGENIC NUCLEOTIDES
The invention features compositions, methods, and systems for single-molecule sequencing of nucleic acids based on the continuous measurement of the incorporation of fluorogenic nucleotides in microreactors. In particular, the invention features fluorogenic compounds for use in nucleic acid sequencing. The invention provides numerous advantages over previous systems such as unambiguous determination of sequence, continuous sequencing, long read lengths, low overall cost, and ease of sample preparation.
1 .- 28 . (canceled)
29 . A compound having the formula:
Base-Sugar-Phosphate-[Self-reacting Component],
where Base is a nucleotide base, Sugar is selected from the group consisting of ribose, 2′-deoxyribose, 2′-O-methyl-ribose, ribose comprising a methylene connecting the 2′ oxygen and 4′ carbon, glycerol, 2-methyl morpholine, or threose, Phosphate is a polyphosphate, and Self-reacting Component is a moiety that undergoes an intramolecular reaction upon cleavage of the phosphate to which it is connected to form a fluorophore.
30 . The compound of claim 29 , wherein Sugar is ribose or 2′-deoxyribose.
31 . The compound of claim 29 , wherein Base is cytosine, guanine, adenine, thymine, uracil, xanthine, hypoxanthine, inosine, orotate, thiomnosine, thiouracil, pseudouracil, 5,6-dihydrouracil, and 5-bromouracil.
32 . The compound of claim 29 , wherein Phosphate is a triphosphate.
33 . The compound of claim 29 , wherein [Self-reacting Component] comprises a self-immolative linker.
34 . The compound of claim 29 , wherein [Self-reacting Component] comprises a moiety that undergoes an intramolecular reaction to form a fluorophore upon removal of the phosphate.
35 . The compound of claim 29 , having the formula:
wherein Q is H, OH, or OMe, n is an integer from 1 to 4; R 1 is cytosine, guanine, adenine, thymine, or uracil; L is a self-immolative linker; and R 2 is a fluorophore bound to said linker via an amine group.
36 . The compound of claim 33 or 35 , wherein said self-immolative
linker is
wherein R is Phosphate; and X—NH is a fluorophore bound to said linker via an amine group.
37 . The compound of claim 36 , wherein X—NH has the formula
wherein each of R 1 -R 11 is independently selected from hydrogen, halogen, sulfonate, carboxy, C 1-6 acyl, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkylthio, a C 1-6 alkyl group interrupted with one or more heteroatoms, C 1-6 haloalkyl group, C 3-6 cycloalkyl, carboxy substituted C 1-6 alkyl, carboxy substituted C 1-6 alkylthio C 6-10 aryl, C 4-9 heteroaryl, nitro, sulfonyl substituted C 1-6 alkyl, or hydroxyl, and each Z is independently C 1-6 acyl, C 1-6 alkyl, sulfonyl, a C 1-6 alkyl group interrupted with one or more heteroatoms, C 1-6 haloalkyl group, C 3-6 cycloalkyl, carboxy substituted C 1-6 alkyl, or sulfonyl substituted C 1-6 alkyl.
38 . The compound of claim 34 , having the formula:
where Q is H, OH, or OMe, n is an integer from 1 to 4; R 1 is cytosine, guanine, adenine, thymine, or uracil; and R 2 is said moiety that undergoes an intramolecular reaction to form a fluorophore upon removal of the phosphate.
39 . The compound of claim 34 or 38 , wherein said moiety that undergoes an intramolecular reaction to form a fluorophore upon removal of the phosphate has the formula:
wherein each R is independently H or C 1-6 alkyl, or both R groups together are C 2-5 alkylene.
40 . A compound having the formula:
where R is a nucleotide base, Q is H, OH, or OMe, n is an integer from 1 to 4, and R 1 -R 10 are independently selected from hydrogen, halogen, sulfonate, carboxy, C 1-6 acyl, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkylthio, a C 1-6 alkyl group interrupted with one or more heteroatoms, C 1-6 haloalkyl group, C 3-6 cycloalkyl, carboxy substituted C 1-6 alkyl, carboxy substituted C 1-6 alkylthio, C 6-10 aryl, C 4-9 heteroaryl, nitro, sulfonyl substituted C 1-6 alkyl or hydroxyl, and X is C 1-6 acyl, C 1-6 alkyl, sulfonyl, a C 1-6 alkyl group interrupted with one or more heteroatoms, C 1-6 haloalkyl group, C 3-6 cycloalkyl, carboxy substituted C 1-6 alkyl, or sulfonyl substituted C 1-6 alkyl, wherein when R 1 -R 10 are H, X is not ethyl.
41 . The compound of claim 40 , having the formula:
42 . The compound of claim 40 , wherein R is cytosine, guanine, adenine, thymine, uracil, xanthine, hypoxanthine, inosine, orotate, thioinosine, thiouracil, pseudouracil, 5,6-dihydrouracil, and 5-bromouracil.
43 . A compound having the formula:
wherein R is a nucleotide base, Q is H, OH, or OMe, n is an integer from 1 to 4, and R 1 -R 10 are independently selected from hydrogen, halogen, sulfonate, carboxy, C 1-6 acyl, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkylthio, a C 1-6 alkyl group interrupted with one or more heteroatoms, C 1-6 haloalkyl group, C 3-6 cycloalkyl, carboxy substituted C 16 alkyl, carboxy substituted C 1-6 alkylthio, C 6-10 aryl, C 4-9 heteroaryl, nitro, sulfonyl substituted C 1-6 alkyl, or hydroxyl, and X is C 1-6 acyl, C 1-6 alkyl, sulfonyl, a C 1-6 alkyl group interrupted with one or more heteroatoms, C 1-6 haloalkyl group, C 3-6 cycloalkyl, carboxy substituted C 1-6 alkyl, or sulfonyl substituted C 1-6 alkyl.
44 . The compound of claim 43 , wherein R is cytosine, guanine, adenine, thymine, uracil, xanthine, hypoxanthine, inosine, orotate, thioinosine, thiouracil, pseudouracil, 5,6-dihydrouracil, and 5-bromouracil.
45 . The compound of claim 43 , having the formula:
46 .- 47 . (canceled)